NU

Nunzia Pharmaceutical CorpOOTC NUNZ Stock Report

Last reporting period 30 Sep, 2022

Updated 11 Nov, 2024

Last price

Market cap $B

0.001

Micro

Exchange

OOTC - OTC

NUNZ Stock Analysis

NU

Uncovered

Nunzia Pharmaceutical Corp is uncovered by Eyestock quantitative analysis.

Market cap $B

0.001

Dividend yield

Shares outstanding

434.51 B

Nunzia Pharmaceutical Corp. engages in the manufacture and sales of drugs. The company is headquartered in Los Angeles, California. The firm manufactures, markets and plan to distribute Nunzia, direct to consumers through its website, www.nunziapharma.com, and through wholesalers. Nunzia is nutraceutical product is designed to treat the symptoms of these wide-ranging medical conditions. Nunzia product is intended to increase sensory, social, and daily living skills, as well as increasing attention span, memory retention, focus, comprehension and learning while decreasing anxiety, stress, fixations, fidgeting and outside detractions.

View Section: Eyestock Rating